Cefdinir
Back to searchMolecule Structure
Scientific Name
Cefdinir
Description of the Drug
Cefdinir is a third generation cephalosporin used to treat susceptible Gram negative and Gram positive bacterial infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00535
http://www.drugbank.ca/drugs/DB00535
Brand Name(s)
Cefdinir, Cefzon, Omnicef
Company Owner(s)
Alkem Laboratories Ltd, Sandoz Inc, Orchid Healthcare, Aurobindo Pharma Ltd, Abbvie Inc, Teva Pharmaceuticals Usa, Lupin Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL36995 | |
| PharmGKB | PA164768739 | |
| Human Metabolome Database | HMDB0014675 | |
| DrugBank | DB00535 | |
| PubChem: Thomson Pharma | 14805465 | 14927923 |
| PubChem | 6915944 | |
| NMRShiftDB | 60027627 | |
| Nikkaji | J227.563E | |
| BindingDB | 50248190 | |
| EPA CompTox Dashboard | DTXSID8046084 | |
| DrugCentral | 533 | |
| Brenda | 37963 | |
| ChemicalBook | CB7483101 | |
| rxnorm | CEFDINIR | OMNICEF |
| PubChem: Drugs of the Future | 12013492 | |
| KEGG Ligand | C08110 | |
| ChEBI | 3485 | |
| ZINC | ZINC000003927198 |
